Answers are grounded in this paper and cite their sources.
The effects of metronidazole, which selectively sensitizes hypoxic cells, on the radiation response of C3H mouse mammary carcinoma and of mouse skin and jejunal epithelium have been investigated. A dose of 2.5 mg of metronidazole/mouse reduced the TCD50 from a control value of 6,360 rads to 5,310, 5,310 and 5,400 rads, at 3, 10 and 30 minutes after i.v. injection, respectively, in mice bearing tumors 8 mm in diameter. The skin response, as measured by the DD50, was also enhanced by metronidazole, the control value being 4,780 rads, compared to 3,980 rads in metronidazole-treated mice. The jejunal epithelium, however, was not sensitized by metronidazole, but conversely, a slight protective effect was observed at high radiation doses. This dose of metronidazole had no effect on tumor growth rate and was not toxic to the mice.
No takes yet. Share an insight, caveat, or question.
Stone et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: